Jody A. Charnow

Editor

Jody A. Charnow has been the editor of Renal & Urology News, a publication of Haymarket Media, since 2003. Previously, he had served as editor of Internal Medicine World Report and a managing editor for Medical Tribune. He holds a BA in biology from the State University of New York at Albany.

All articles by Jody A. Charnow

General Rheumatology

High Death Rate Observed in COVID-19-Associated Acute Kidney Injury Requiring Dialysis

Jody A. Charnow

May 11, 2021

Nearly two-thirds of hospitalized patients with COVID-19 and acute kidney injury requiring dialysis died during their hospital stay, a study found.

News

Why Racial and Ethnic Disparities Exist in Kidney Disease Care

Jody A. Charnow

April 20, 2021

Lack of timely referrals to nephrologists contribute to racial and ethnic disparities in kidney disease care.

Gout

Pegloticase Use for Uncontrolled Gout in the Dialysis Population Described

Jody A. Charnow

April 16, 2021

New study is the first to characterize pegloticase use in the dialysis population.

General Rheumatology

Sodium Abnormalities Common at Hospital Admission for COVID-19

Jody A. Charnow

April 13, 2021

Nearly 52% of adult patients hospitalized for COVID-19 in the metropolitan New York region had hyponatremia or hypernatremia at admission, a study found.

Systemic Lupus Erythematosus

Higher Initial Prednisone Dose for New-Onset Lupus Nephritis Offers Superior Efficacy

Jody A. Charnow

March 22, 2021

Patients with new-onset lupus nephritis achieve significantly higher rates of complete response at 1, 2, and 3 years if they receive a higher initial dose of prednisone for remission induction, a study found.

Obesity Cuts Life Expectancy in Diabetes

Gout

Gout May Be a Possible Indication for Bariatric Surgery

Jody A. Charnow

February 9, 2021

Of 25 patients with both obesity and gout who had elevated uric acid levels prior to bariatric surgery, 10 achieved therapeutic target levels of uric acid at 12 months after the surgery, according to investigators.

Systemic Lupus Erythematosus

Kidney Disease in SLE Possible Despite Low-Level Proteinuria

Jody A. Charnow

February 4, 2021

Based on new findings from a study of patients with systemic lupus erythematosus, investigators suggest revising current guidelines to expand kidney biopsy indications to include isolated proteinuria of any grade.

Systemic Lupus Erythematosus

Factors Associated With Rapid Progression to End-Stage Kidney Disease in Lupus Nephritis Identified

Jody A. Charnow

January 11, 2021

A small study suggests that poor medication compliance and certain histopathologic features may be associated with development of end-stage kidney disease within 3 years of lupus nephritis diagnosis.

NKF 2017-prescription pill bottles, capsule pills

Systemic Lupus Erythematosus

New Study Supports Voclosporin Use in Lupus Nephritis

Jody A. Charnow

November 2, 2020

Pooled analyses from 2 clinical trials show that voclosporin, a novel calcineurin inhibitor, is safe and effective in managing lupus nephritis.

Gout

Pegloticase Safe, Effective for Refractory Gout in Kidney Transplant Recipients

Jody A. Charnow

October 29, 2020

Early data from a small ongoing trial shows that pegloticase, which is administered by injection, can result in substantial and sustained decreases in serum uric acid in kidney transplant recipients with treatment-refractory gout.

Next post in Gout